Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Gross Margin: 2012-2025

Historic Gross Margin for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Sep 2025 value amounting to 100.00%.

  • Enanta Pharmaceuticals' Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2025, which is negligibly% changed negligibly from last year.
  • Enanta Pharmaceuticals' Gross Margin amounted to 100.00% in Q3 2025, which was down 0.00% from 100.00% recorded in Q2 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Gross Margin registered a high of 100.00% during Q1 2021, and its lowest value of 100.00% during Q1 2021.
  • Moreover, its 3-year median value for Gross Margin was 100.00% (2025), whereas its average is 100.00%.